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A new approach for isolating and recovering biological macromolecules using membrane-encapsulated 
soluble ligand conjugates was investigated. Membrane-encapsulated solid adsorbents have been suc- 
cessfully developed and employed in our laboratory to isolate and purify proteins and enzymes directly 
from culture broths. This new concept also makes it possible to use soluble ligand conjugates instead 
of  solid adsorbents inside membrane capsules. In this work, model membrane-encapsulated soluble 
and insoluble ligands comprising Blue Dextran and Blue Sepharose entrapped within calcium alginate 
membranes were studied to compare adsorption characteristics such as capacities and rates. Experi- 
mental results suggest that membrane-encapsulated soluble ligands may be expected to result in higher 
overall adsorption capacity compared to membrane-encapsulated solid adsorbents with comparable 
adsorption rates. 
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Introduction 
Currently a number of techniques are being commer- 
cialized to produce valuable therapeutic proteins from 
different host systems. Regardless of which host is 
used for protein synthesis, considerable engineering 
problems are faced in isolating and purifying biological 
molecules from crude protein mixtures. A trace amount 
of synthesized product is usually present in a colloidal 
suspension contaminated with a large number of pro- 
teins and other macromolecules. Conventional solids 
separation methods such as centrifugation and filtration 
are often inefficient in removing colloidal solids from 
these viscous broths. Most primary isolation steps are 
nonspecific, relying mainly on differences in molecular 
size, charge, or hydrophobic interactions. These lead 
to lower product yields in subsequent isolation and 
purification steps. 
Affinity interactions based on biological recognition 
offer a powerful tool for separating bioproducts. Ide- 
ally, the use of affinity separation in early stages of 
primary isolation may result in a significant increase in 
process yield because of increased selectivity. Table 1 
shows some examples of affinity-based isolation 
methods that can potentially be used at an early stage 
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of a bioseparation process. Besides direct batch ad- 
sorption using small solid affinity adsorbents, 1 two 
other processes, which combine biospecific adsorption 
with aqueous two-phase extraction, have been sug- 
gested in the literature. One uses solid affinity adsor- 
bents, 2'3 and the other one uses water-soluble poly- 
mer-ligand conjugates, 4-7 in combination with aqueous 
two-phase extraction. In the first case, solid adsorbent 
particles with the adsorbed bioproduct can be parti- 
tioned into the upper polyethylene glycol (PEG)-rich 
phase, while contaminants such as cell debris move 
to the lower dextran-rich phase. An alternative is to 
covalently bond affinity ligands to one of the polymers 
used in the aqueous two-phase extraction, such as 
PEG, to form one of the separating phases. The desired 
product can then be preferentially pulled into the upper 
PEG-rich phase, while most of the contaminant pro- 
teins and cell debris are partitioned into the lower dex- 
tran-rich phase. However, problems associated with 
aqueous two-phase extraction, such as reagent costs 
and large-scale processing of viscous fluids, have to be 
addressed for broader applications. For example, new, 
lost-cost polymers specially designed for aqueous two- 
phase systems have been studied. 8 
Membrane-encapsulated semi-specific and specific 
solid affinity adsorbents have been proposed and inves- 
tigated in our laboratory. The advantages and disad- 
vantages of using membrane-encapsulated adsorbents 
are discussed elsewhere. 1'9-1° Briefly, the hydrophilic 
capsule membrane can be used to prevent adhesion of 
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Table 1 Affinity-based isolation methods at whole broth stage 
Process Form of affinity ligand Recovery of ligands Problems 
Direct batch adsorption Solid adsorbent Sedimentation eFouling 
particles oDifficulty in recovery of fine 
Aqueous two-phase partitioning 
with carrier adsorbents 
Aqueous two-phase affinity 
partitioning 










oHigh cost of reagents 
oLimited range of operating 
physicochemical conditions 
eDifficulty in separation of 
bioproduct from phase 
forming polymer 
oEncapsulation Technology? 










colloidal solids and nonspecific adsorption of macro- 
molecular contaminants to the affinity adsorbents. 
Also, encapsulated adsorbents can be designed large 
enough to allow easy recovery from culture broths. 
The problem of creating an additional intramembrane 
diffusion resistance may be minimized by using soluble 
polymer-ligand conjugates instead of solid adsorbents 
within the membrane capsules, as illustrated in Figure 
1. Ligands covalently immobilized onto various macro- 
molecular water-soluble polymers can be encapsulated 
within different semipermeable membranes. The cap- 
sule membrane's characteristics can be tailored to pre- 
vent the soluble ligands from leaking out of the capsules 
and yet allow the desired bioproduct easily to diffuse 
into the capsules and be bound to the immobilized 
soluble ligands. 
In this study, experiments were carried out to dem- 
onstrate this concept and to compare the adsorption 
properties of a membrane-encapsulated insoluble li- 
gand versus a soluble ligand. Blue Dextran and Blue 
Sepharose were used as model affinity and/or semi- 
affinity ligands in this study. We intend to prove the 
feasibility of using membrane-encapsulated soluble li- 
gands as a new bioseparation tool and evaluate its char- 
acteristics. 
Materials and methods 
Materials 
The following chemicals were used: dextran (MW = 
42,600), HEPES, human serum albumin (HuSA), Reac- 
tive Blue 2-Sepharose (Blue Sepharose), Blue Dextran 
from Sigma (St. Louis, MO), calcium chloride from 
Baker (Phillipsburg, N J), and sodium alginate (Kelco 
Gel LV) from Kelco (Chicago, IL). 
Model experimental system 
Two kinds of commercially available ligand-carrier 
conjugates that have the same group-specific ligand, 
Reactive Blue 2, were used in these experiments. One 
is Blue Dextran, which is a water-soluble conjugate 
composed of the ligand and water-soluble polymer dex- 
tran with a molecular weight of approximately 2 x 10 6. 
The other is Blue Sepharose, which is an insoluble solid 
adsorbent with a particle diameter of 80-200 p~m. These 
two were encapsulated within calcium alginate mem- 
branes. Human serum albumin (HuSA) can be specifi- 
cally bound to this ligand.11-13 The molecular weight of 
HuSA is 66,000 and the diffusion coefficient of this 
protein in water, Do, is 6.1 x 10 -7  c m  2 s -1 .  
Preparation of Ca-alginate beads 
Calcium alginate beads were used to measure the effec- 
tive diffusivities of HuSA in calcium alginate gel by 
batch diffusion experiments, as described in the litera- 
ture. 14 Sodium alginate solutions (0.5%, I%, 2%, and 
4%; w/v) were prepared using deionized water. Drop- 
lets of these solutions were introduced into a well- 
stirred 0.5% (w/v) calcium chloride solution. The cal- 
cium alginate beads were instantaneously formed and 
cured in the 0.5% (w/v) calcium chloride solution until 
use. The beads were placed in a 25 mM HEPES buffer 
(pH 7.0) containing 5 mM calcium chloride for 3 h prior 
to the diffusion experiments. 
Encapsulation of ligands in Ca-alginate 
membrane 
The basic approach to encapsulating various bioactive 
materials, including affinity ligands, has been devel- 
oped in our laboratory and is described in the litera- 
ture. 15 A precisely measured amount of Blue Sepharose 
was suspended in a solution containing 0.5% (w/v) cal- 
cium chloride and 20% (w/v) dextran. Dextran serves 
as a viscosity enhancer to ensure a spherical shape 
for the capsules. ~ Most of the dextran diffuses out 
of the capsule after the encapsulation is completed. 
Similarly, a precisely weighed amount of Blue Dextran 
was dissolved in a solution containing 0.5% (w/v) cal- 
cium chloride and 20% (w/v) dextran. Droplets of this 
prepared suspension were dropped through a hypoder- 
mic needle into a rapidly stirred 0.5% (w/v) sodium 
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(a) Encapsulated soluble 
polymer-ligand conjugates 
(b) Encapsulated solid 
adsorbents 
Figure 1 Bioproduct recovery using membrane-encapsulated ligands 
alginate solution. Capsular membranes were formed 
instantaneously around the droplets and wrapped the 
suspension containing Blue Dextran due to rapid cross- 
linking of alginate molecules by calcium cations at the 
interface. The Blue Dextran capsules formed were al- 
lowed to stand in the alginate solution for 1 min. After 
that, the sodium alginate solution was diluted five- 
fold with deionized water and the capsules were recov- 
ered from the solution. The capsules were then washed 
twice with deionized water and stored in a 0.5% (w/v) 
calcium chloride solution overnight before use. 
Diffusion o f  H u S A  into Ca-alginate beads 
One or two milliliters of calcium alginate beads pre- 
pared as described earlier were completely freed of 
excess buffer solution by filtering with a fine mesh 
and then placed in 5 ml of 1 mg ml-I  HuSA solution 
prepared using the same H E P E S  buffer solution de- 
scribed before.  This buffer solution was used in all the 
experiments in this work. The suspension was kept 
mixed on a rotator. Temperature  was maintained at 
20°C. HuSA concentrat ion was determined by absorb- 
ance at 280 nm. 
Adsorption o f  H u S A  onto encapsulated ligands 
Adsorption equilibrium and rate data were obtained 
by batch adsorption experiments.  Capsules containing 
various soluble or insoluble ligands prepared as de- 
scribed previously were equilibrated in 25 mM H EP ES  
buffer containing 5 mM CaC12 (pH 7.0) for 3 h before 
use. Between 0.1 and 2 ml of the capsules were placed 
in 5 ml of 1 mg ml-  l HuSA solution for batch adsorption 
experiments.  
Results and discussion 
Preparation o f  the encapsulated ligands 
The effective diffusivity, D e, of  proteins in calcium 
alginate gels is significantly dependent  on gel concen- 
tration and also varies with proteins of  different molec- 
ular size and charge. 14'16-18 D e may also vary with the 
preparation procedures and the type of  sodium alginate 
used. For  a given sodium alginate concentrat ion,  the 
HuSA concentrat ion changes with respect  to time dur- 
ing batch diffusion is shown in Figure 2, where C is the 
HuSA concentrat ion,  C O is the initial concentration, 
and C* is defined by equation (1): 
c *  = VsCo/(V~ + vb) (l)  
where Vs and V, represent  the volumes of  a HuSA 
solution and calcium alginate beads used, respectively. 
A solid line in Figure 2 represents the theoretial 
profile of diffusion from a well-stirred solution of  lim- 
ited volume into a sphere, 19 which is given by equation 
(2) with D e = D O = 6.1 x 10 - 7  c m  2 s - 1 ,  where D O is 
the bulk diffusivity of  HuSA. 
C _ ~ 1 + 6(1 + ~)exp(-Dcq~t/R2)~ 
C O 1 + a = 9 + 9a + q2o~2 J 
(2) 
where a = Vs/Vb and q, terms are the roots of  equation 
(3) 
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Diffusion of HuSA into Ca-alginate beads 
tan qn = 3q,/(3 + aq]) (3) 
The mean radius of beads, Rb, was determined from 
equation (4): 
V h = 47rR3N/3 (4) 
where N is the number of beads used. 
Experimental data for HuSA diffusion into 0.5% (w/ 
v) calcium alginate are successfully fitted by this pro- 
file, suggesting that D e of HuSA in 0.5% calcium algi- 
nate can be considered to be equivalent to D o. When 
affinity ligands are encapsulated within the capsule 
membranes, it is desirable to make the membrane loose 
enough to allow the passage of the desired protein with 
minimum diffusion resistance. Because of this, Blue 
Sepharose and Blue Dextran were initially encapsu- 
lated within calcium alginate gel membranes prepared 
from 0.5% (w/v) sodium alginate solutions. 
Capsule size could be controlled to a diameter from 
0.04 to 0.4 cm using a microdroplet generator similar to 
the one used by Klein et  al. 16 Examples of membrane- 
encapsulated Blue Sepharose and Blue Dextran are 
shown in Figures  3a and b respectively. 
A d s o r p t i o n  c a p a c i t y  
The adsorption equilibrium of HuSA on Blue Sepha- 
rose and Blue Dextran in 25 mM HEPES buffer contain- 
ing 5 mM CaC12 (pH 7.0) is shown in Figure  4, on 
the basis of dry carrier weight. Equilibrium data were 
successfully correlated by the Langmuir isotherm: 
q = Kq*C/(1 + KC)  (5) 
where q is the amount adsorbed in equilibrium with the 
concentration C, q* is the saturated amount adsorbed, 
and K is the Langmuir constant. The parameters, q* 
and K, were determined using the Langmuir plots. The 
resultant correlation curves are shown in Figure  4, with 
the estimated parameters given in the figure caption. 
The effective ligand density of Blue Dextran on a dry 
weight basis is approximately one order of magnitude 
higher than that of Blue Sepharose. Higher ligand den- 
sity in solid supports may be restricted because of 
other problems, such as steric hindrance of the immobi- 
lized iigands in the gel matrices, which in turn reduces 
the effective binding capacity. 
Overall adsorption capacity based on capsule vol- 
ume is compared in Table 2. The upper limit values 
of the carrier concentration in the capsule core are 
estimated values determined from the experiments. In 
a series of encapsulation studies, it was found that 
encapsulation of Blue Sepharose and Blue Dextran 
with higher concentrations than these was difficult to 
achieve experimentally. These results suggest that sol- 
uble ligands in capsules can be used as an alternative 
to obtain a higher overall adsorption capacity com- 
pared to solid adsorbents. 
A d s o r p t i o n  r a t e  
The adsorption rate was evaluated in terms of the ap- 
parent overall effective diffusivity in the capsule core, 
De,app. A theoretical model describing mass transfer of 
HuSA from a bulk solution to encapsulated ligands was 
used to evaluate D~,ap p from these experimental data. 
Since the details of this model have been described 
elsewhere,re'2° only the basic equations and boundary 
conditions will be cited in this paper. 
The mass balance inside the capsule core is: 
De,app a ( oc, ] oc, 
r 2 Or r2 - -  + (6) / = ~ at Pc at 
The mass balance in the capsule membrane is: 
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Table 2 Comparison of adsorption capacity 
Blue Sepharose Blue Dextran 
(insoluble) (soluble) 
q*[mg-HuSA/g-dry carrier] 75 833 
Upper limit of carrier 0.150 0.075 
concentration in the 
capsule core 
[g dry carrier m1-1 capsule] 
Overall adsorption 10 60 
capacity 






Figure 3 (a) Encapsulated Blue Sepharose. (b) Encapsulated 
Blue Dextran 
DeO {r20Ci~ OCi (7) 
r2 ar " -~r = S 0-"7 
Boundary conditions are: 
r = O; OC~ = 0 (8) 
Or 
r = r c D e ,vp OC----Ai = D OC---i (9) 
' Or  e Or 
r =  R c C i =  C (10) 
The assumptions made were: (1) the capsule core con- 
sisting of Blue Sepharose particles in suspension is 
approximated as an evenly dispersed phase; (2) the 
encapsulated Blue Dextran solution is considered to be 
immobile inside the membrane capsule; (3) the molecu- 
lar diffusion of Blue Dextran is negligible in comparison 
with that of HuSA. Although the model employed here 
as a first approximation may not be adequate to de- 
scribe the exact mass transfer mechanisms, it should 
still give us a rough estimate of the overall effective 
diffusivities of these two kinds of encapsulated ligand 
systems for comparison. 
F i g u r e s  5 and 6 show experimental data and fitting 
curves of bulk concentration changes when encapsu- 
lated Blue Sepharose and Blue Dextran are used, re- 
spectively. The resultant values of De,ap p a r e  given in 
figure captions, along with the values of capsule radius 
R,, ,  capsule core radius G, Blue Sepharose and Blue 
Dextran concentration in capsule cores on the dry 
weight basis Pc, and adsorption capacity of the cap- 
sules. The De,ap p values obtained in these two systems 
were about the same order of magnitude and they were 
approximately one order of magnitude smaller than the 
bulk diffusivity. This is primarily due to the support gel 
matrix in the case of Blue Sepharose and the highly 
viscous nature of the polymer-ligand conjugate solu- 
tion for Blue Dextran. Possible reasons for the inade- 
quacy of the model predictions in comparison with 
experimental data are likely due to some of the simplify- 
ing assumptions made for this kinetic model. More 
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Figure 4 Adsorption equil ibrium of HuSA on encapsulated Blue 
Sepharose and Blue Dextran. Blue Sepharose: K = 5.15 ml mg -1, 
q* = 74.6 mg g- l .  Blue Dextran: K = 1.03 ml mg -1, q* = 833 mg 
g-1 
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Figure 5 Batch adso rp t i on  prof i le  of  HuSA  on encapsu la ted  
Blue Sepharose .  Rc = 0.072 cm,  rc = 0.064 cm, pc = 0.113 g m1-1. 
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Figure 6 Batch adso rp t i on  prof i le  o f  HuSA on encapsu la ted  
Blue Dext ran .  Rc = 0.094 cm,  rc = 0.086 cm, #c = 0.025 g m1-1. 
A d s o r p t i o n  capac i t y  = 20.8 mg  ml =~. De, app = 4.0 x 10 -8 cm 2 s -1. 
Rc = 0.104 crn, r c = 0,096 cm, Pc = 0.010 g ml ~. A d s o r p t i o n  
capac i ty  = 8.3 mg  m1-1. De, app = 6.1 x 10 -8 cm 2 s -1 
to delineate and identify these differences and possible 
methods to improve the kinetic models. 
Conclusions 
A new approach for isolating and recovering biological 
molecules, such as proteins and polypeptides, using 
membrane-encapsulated water-soluble ligand conju- 
gates was studied using a simplified encapsulation tech- 
nique. These new membrane-encapsulated soluble 
polymeric conjugates were compared with the use of 
solid adsorbents in terms of the adsorption capacity 
and rate. Blue Sepharose particles and Blue Dextran 
solutions were successfully encapsulated within a cal- 
cium alginate hydrogel membrane having well-defined 
characteristics. Experimental data suggest that the use 
of soluble ligands can be expected to result in a higher 
overall adsorption capacity compared to solid adsor- 
bents. The adsorption rate of the membrane-encapsu- 
lated soluble ligands is only comparable to that of en- 
capsulated insoluble ligands because of diffusional 
restriction due to the highly viscous nature of the solu- 
ble polymer-ligand conjugate solution. 
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concentration of HuSA, mg ml- 
HuSA concentration in capsule and bead, 
mg ml 
initial concentration, mg ml -~ 
defined by equation (1) mg ml-1 
effective diffusivity in calcium alginate gel, 
c m  2 s -  1 
apparent overall effective diffusivity in the 
capsule core, cm 2 s -1 
diffusivity in water, cm 2 s- 
Langmuir constant, ml rag- 
number of beads, - 
amount adsorbed, mg g- 
nth root of equation (3), - 
saturation amount adsorbed, mg g- 
radial distance, cm 
capsule core radius, cm 
capsule radius, cm 
bead radius, cm 
time, s 
volume of protein solution, ml 
total volume of beads, ml 
ratio of solution volume to bead volume, - 
ligand carrier concentration in capsule core, 
g m1-1 
References 
1 Wang, H. Y. and Sobnosky, K. ACS Syrup Ser. 1986, 271, 123 
2 Hedman, P. and Gustafsson, J. G. Anal. Biochem. 1984, 138, 
411-415 
3 Frej, A-K., Gustafsson, J-G. and Hedman, P. Biochem. Bi- 
oeng. 1986, 28, 133-137 
4 Flanagan, S. D. and Barondes, S. H. J. Biol. Chem. 1975, 250, 
1484-1489 
5 Kula, M. R., Johansson, G. and Buckmann, A. F. Biochem. 
Soc. Trans. 1979, 7, 1-5 
6 Kopperschlager, G. and Johansson, G. Anal. Biochem. 1982, 
124, 117-124 
7 Harris, J. M., Case, M. G. and Hovanes, B. A. Ind. Eng. 
Chem. Prod. Res. Dev. 1984, 23, 86-88 
8 Tjerneld, F., Johansson, G. and Joelsson, M. Biotech, Bioeng. 
1987, 30, 809-816 
9 Nigam, S. C., Sakoda, A. and Wang, H. Y. Biotech. Progress 
1988, 4, 166-172 
10 Sakoda, A. and Wang, H. Y. Biotechnol. Bioeng. 1989, 34, 
1098-1103 
11 Angal, S. and Dean, P. D. G. Biochem. J. 1977, 167, 301-303 
12 Leatherbarrow, R. J. and Dean, P. D. G. Biochem. J. 1980, 
189, 27-34 
13 Lagercrantz, C. and Larsson, T. Biochem. J. 1983,213,387-390 
14 Tanaka, H., Matsumura, M. and Veliky, I. A. Biotech. Bioeng 
1984, 26, 53-58 
15 Nigam, S. C., Tsao, I-Fu, Sakoda, A. and Wang, H. Y. Biotech. 
Techniques 1988, 2, 271-276 
16 Klein, J., Stock, J. and Vorlop, K. D. Eur. J. Appl. Microb. 
Biotech. 1983, 18, 86-91 
17 Hannoun, B. J. M. and Stephanopoulos, G. Biotech. Bioeng. 
1986, 28, 829-835 
18 Itamunoala, G. F. Biotech. Prog. 1987, 3, 115-120 
19 Crank, J. in Mathematics o f  Diffusion Clarendon, Oxford, 
1956, Chapter 6 (p. 93) 
20 Nigam, S. C. Ph.D. Thesis University of Michigan, 1988 
354 Enzyme Microb. Technol., 1990, vol. 12, May 
